A prospective phase I and consecutive phase II, twoarm, randomized multi-center trial of temsirolimus in combination with pioglitazone, etoricoxib and metronomic low-dose trofosfamide versus dacarb...

Update Il y a 4 ans
Reference: EUCTR2011-002611-29

A prospective phase I and consecutive phase II, twoarm, randomized multi-center trial of temsirolimus in combination with pioglitazone, etoricoxib and metronomic low-dose trofosfamide versus dacarbazine (DTIC) in patients with advanced melanoma

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Phase I: To determine the dose of temsirolimus to be used in phase II part of the study Phase II: To determine overall survival


Inclusion criteria

  • metastatic melanoma or metastatic uveal carcinoma

Links